GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of MAP kinase activity | ||
adaptive immune response |
|
|
sphingosine-1-phosphate receptor signaling pathway | ||
G protein-coupled receptor signaling pathway | ||
cell migration |
GO Term | Evidence Code | PMID |
---|---|---|
kinase activity | ||
ephrin receptor binding | ||
1-phosphatidylinositol-3-kinase activity | ||
protein serine/threonine kinase activity | ||
protein serine kinase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110760 | type 1 diabetes mellitus 23 | |
DOID:0110761 | type 1 diabetes mellitus 24 | |
DOID:0110844 | xeroderma pigmentosum group C | |
DOID:0110858 | polycystic kidney disease 1 | |
DOID:0110892 | inflammatory bowel disease 1 | |
DOID:0110910 | leukocyte adhesion deficiency 1 | |
DOID:0111005 | cone-rod dystrophy 2 | |
DOID:0111029 | hemochromatosis type 1 | |
DOID:0111135 | congenital generalized lipodystrophy type 1 | |
DOID:0111136 | congenital generalized lipodystrophy type 2 |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000403 | Recurrent otitis media |
HP:0000964 | Eczematoid dermatitis |
HP:0001252 | Hypotonia |
HP:0001433 | Hepatosplenomegaly |
HP:0001581 | Recurrent skin infections |
HP:0001742 | Nasal congestion |
HP:0001744 | Splenomegaly |
HP:0001873 | Thrombocytopenia |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
101096215 | FELCA03042 | ||
122206263 | PANLE22381 | ||
101336571 | TURTR01860 | ||
118900854 | BALMU12651 | ||
100673566 | LOXAF17782 | ||
100050532 | HORSE33500 | ||
396979 | PIGXX36424 | ||
530001 | BOVIN27946 | ||
102173256 | CAPHI23797 | ||
101102896 | SHEEP15440 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024